Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07295171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG

Study acronym: HELP
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Primary completion date changed from estimate of Dec 15, 2026 to Aug 25, 2026 · Completion pushed from Feb 18, 2027 to Aug 25, 2027 · Start date: Feb 18, 2026 to Feb 10, 2026 · 3 more Show 6 more changesShow less
    • Primary completion date changed from estimate of Dec 15, 2026 to Aug 25, 2026
    • Completion pushed from Feb 18, 2027 to Aug 25, 2027
    • Start date: Feb 18, 2026 to Feb 10, 2026
    • Eligibility criteria expanded, about 17 words
    • Study description revised
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Feb 15, 2026 to Dec 15, 2026 · Completion date: Feb 15, 2027 to Feb 18, 2027 · Start date changed from estimate of Jan 15, 2026 to Feb 18, 2026 · 1 morev2 Show 4 more changesShow less
    • Primary completion date: Feb 15, 2026 to Dec 15, 2026
    • Completion date: Feb 15, 2027 to Feb 18, 2027
    • Start date changed from estimate of Jan 15, 2026 to Feb 18, 2026
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG. This study aims to assess the feasibility of a different method of administration - oral ingestion (rather than IV) of 18F-FDG through delayed imaging to identify the optimal time for scanning after consuming the drug. The study will aim to recruit 15-24 individuals who will receive two PET scans - one using delayed oral 18F-FDG imaging and a second regular 18F-FDG. The analysis will focus on establishing a suitable protocol for this administration route while considering patient preference and image quality.
Trial Details
NCT Number NCT07295171
Lead Sponsor British Columbia Cancer Agency
Conditions Multiple Cancers, Multiple Indications Cancer, Feasibility Studies
Enrollment 27 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov